EP4215621 - QUANTIFICATION OF NUCLEOSOME MODIFICATIONS USING CHEMICALLY-DEFINED RECOMBINANT NUCLEOSOMES [Right-click to bookmark this link] | Status | Grant of patent is intended Status updated on 13.08.2024 Database last updated on 19.10.2024 | |
Former | Examination is in progress Status updated on 16.02.2024 | ||
Former | Request for examination was made Status updated on 26.01.2024 | ||
Former | The application has been published Status updated on 23.06.2023 | Most recent event Tooltip | 13.08.2024 | New entry: Communication of intention to grant a patent | Applicant(s) | For all designated states Epicypher, Inc. 801 Capitola Drive Suite 9 Research Triangle Park, North Carolina 27713 / US | [2023/30] | Inventor(s) | 01 /
JOHNSTONE, Andrea L Durham / US | 02 /
COWLES, Martis William Durham / US | 03 /
WHELIHAN, Matthew F Durham / US | 04 /
MARUNDE, Matthew R Durham / US | 05 /
KOEGH, Michael-Christopher Durham / US | 06 /
HALL, Nathan W Durham / US | 07 /
SUN, Zu-Wen Durham / US | [2023/30] | Representative(s) | Appleyard Lees IP LLP 15 Clare Road Halifax HX1 2HY / GB | [2023/30] | Application number, filing date | 23157465.8 | 01.03.2019 | [2023/30] | Priority number, date | US201862637066P | 01.03.2018 Original published format: US 201862637066 P | [2023/30] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP4215621 | Date: | 26.07.2023 | Language: | EN | [2023/30] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 01.06.2023 | Classification | IPC: | C12Q1/6851, C12Q1/6804, G01N33/53, G01N33/68, C12Q1/6806 | [2023/30] | CPC: |
G01N33/6875 (EP);
C12Q1/6804 (EP,US);
C12Q1/6806 (EP);
C12Q1/6811 (US);
C12Q1/6883 (EP);
G01N33/49 (US);
C12Q2600/118 (EP);
C12Q2600/156 (EP);
C12Y301/31001 (US);
G01N2440/18 (EP)
(-)
| C-Set: |
C12Q1/6804, C12Q2521/301, C12Q2522/10, C12Q2545/113 (EP);
C12Q1/6804, C12Q2522/10, C12Q2545/101 (EP);
C12Q1/6806, C12Q2521/301, C12Q2522/10, C12Q2545/113 (EP);
C12Q1/6806, C12Q2522/10, C12Q2545/101 (EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/09] |
Former [2023/30] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | QUANTIFIZIERUNG VON NUKLEOSOMMODIFIKATIONEN MIT CHEMISCH DEFINIERTEN REKOMBINANTEN NUKLEOSOMEN | [2023/30] | English: | QUANTIFICATION OF NUCLEOSOME MODIFICATIONS USING CHEMICALLY-DEFINED RECOMBINANT NUCLEOSOMES | [2023/30] | French: | QUANTIFICATION DE MODIFICATIONS DE NUCLÉOSOMES À L'AIDE DE NUCLÉOSOMES RECOMBINANTS DÉFINIS CHIMIQUEMENT | [2023/30] | Examination procedure | 24.01.2024 | Examination requested [2024/09] | 24.01.2024 | Date on which the examining division has become responsible | 14.02.2024 | Despatch of a communication from the examining division (Time limit: M04) | 24.05.2024 | Reply to a communication from the examining division | 14.08.2024 | Communication of intention to grant the patent | Parent application(s) Tooltip | EP19760658.5 / EP3759249 | Fees paid | Renewal fee | 20.02.2023 | Renewal fee patent year 03 | 20.02.2023 | Renewal fee patent year 04 | 27.02.2023 | Renewal fee patent year 05 | 03.01.2024 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2005019826 (CHROMA THERAPEUTICS LTD [GB], et al); | [A]WO2015104431 (PROTEROS BIOSTRUCTURES GMBH [DE]); | [A]WO2015117145 (UNIV CHICAGO [US]); | [A]WO2017034970 (MASSACHUSETTS GEN HOSPITAL [US], et al); |